Other tumors harboring ARID1A mutations are uterine endometrioid carcinoma (47–60%), ovarian endometrioid carcinoma (30%), gastric cancer (29%), colorectal cancer (5–10%), and pancreatic cancer (3–5%) [23,24,25,26]. Here, ARID1A is linked to ovarian endometrioid carcinoma.